UK Life Sciences Boom

Good times for UK Life Science Surging energy prices, a cost-of-living crisis, looming stagflation and struggling stock markets: 2022’s financial headlines have seemed almost universally negative. Amidst all this gloom, it should notRead More

Pharmaceutical Industry Reputation Post-COVID

The modern Pharma industry has long had issues around “reputation” and much of the criticism has often centred on drug pricing. Commercial organisations developing and selling life changing and life-saving products are heldRead More